ELI LILLY & Co SEC filings LLY
ELI LILLY & Co has 1,001 filings in SEC EDGAR's recent list, going back to Feb 3, 2022. Its latest annual report, Form 10-K, was filed on Feb 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B2 | Prospectus | May 8, 2026 | — |
| FWP | Free writing prospectus | May 6, 2026 | — |
| 424B2 | Prospectus | May 6, 2026 | — |
| 424B2 | Prospectus | Aug 19, 2025 | — |
| FWP | Free writing prospectus | Aug 18, 2025 | — |
| 424B2 | Prospectus | Aug 18, 2025 | — |
| S-3ASR | Automatic shelf registration | Feb 19, 2025 | — |
| 424B2 | Prospectus | Feb 11, 2025 | — |
| FWP | Free writing prospectus | Feb 10, 2025 | — |
| 424B2 | Prospectus | Feb 10, 2025 | — |
| 424B2 | Prospectus | Aug 13, 2024 | — |
| FWP | Free writing prospectus | Aug 12, 2024 | — |
| 424B2 | Prospectus | Aug 12, 2024 | — |
| 424B2 | Prospectus | Feb 8, 2024 | — |
| FWP | Free writing prospectus | Feb 7, 2024 | — |
| 424B2 | Prospectus | Feb 7, 2024 | — |
| 424B2 | Prospectus | Feb 24, 2023 | — |
| FWP | Free writing prospectus | Feb 23, 2023 | — |
| 424B2 | Prospectus | Feb 23, 2023 | — |
| S-3ASR | Automatic shelf registration | Feb 24, 2022 | — |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LLY (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- IN
- Headquarters
- Indianapolis, IN
- SEC filer status
- Large accelerated filer
- SEC CIK
- 59478
- Former names
- LILLY ELI & CO (until Oct 25, 2019); LILLY ELI & CO ET AL (until Oct 14, 1994)
Other Pharmaceutical Preparations companies
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.